Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 8
Submit an article Journal homepage
207
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia

Sanja PrijićClinical Unit of Cellular Immunodiagnostics and In Vitro Procedures, Clinical Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, CroatiaCorrespondence[email protected]
,
Ivo UgrinaGenos d.o.o., Zagreb, Croatia
,
Boris LabarCenter for Expert Medicine, Zagreb, Croatia
,
Damir NemetDepartment of Hematology, University Hospital Center Zagreb, Zagreb, Croatia;School of Medicine, University of Zagreb, Zagreb, Croatia
,
Josip BatinićDepartment of Hematology, University Hospital Center Zagreb, Zagreb, Croatia;School of Medicine, University of Zagreb, Zagreb, Croatia
,
Renata ZadroClinical Unit of Special and Molecular Hematology, Clinical Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia
,
Sunčica RiesDepartment of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia
,
Koraljka Gjadrov-KuvedžićDepartment of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia
,
Sanja DavidovićClinical Unit of Cytogenetics and FISH Diagnostics of Hemato-oncological Disease, Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia
&
Drago BatinićClinical Unit of Cellular Immunodiagnostics and In Vitro Procedures, Clinical Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia;School of Medicine, University of Zagreb, Zagreb, Croatia
 show all
Pages 2281-2288 | Received 08 Aug 2014, Accepted 26 Nov 2014, Published online: 29 Dec 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marte Karen Brattås, Håkon Reikvam, Tor Henrik Anderson Tvedt & Øystein Bruserud. (2019) Precision medicine for TP53-mutated acute myeloid leukemia. Expert Review of Precision Medicine and Drug Development 4:5, pages 263-274.
Read now
Benedito A Carneiro, Jason B Kaplan, Jessica K Altman, Francis J Giles & Leonidas C Platanias. (2015) Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. Cancer Biology & Therapy 16:5, pages 648-656.
Read now

Articles from other publishers (6)

Huanxin Sun, Xiaowen Liu, Laicheng Wang, Bin Cui, Wenli Mu, Yu Xia, Shuang Liu, Xin Liu, Yulian Jiao & Yueran Zhao. (2022) Dexamethasone Sensitizes Acute Monocytic Leukemia Cells to Ara-C by Upregulating FKBP51. Frontiers in Oncology 12.
Crossref
Débora Felícia Vieira Ramos, Rubia Isler Mancuso, Bruna Contieri, Adriana Duarte, Luciana Paiva, Jeferson de Melo Carrilho, Sara Teresinha Olalla Saad & Mariana Lazarini. (2022) Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition. Toxicology and Applied Pharmacology 442, pages 115990.
Crossref
Mays AbuhantashEmma M. CollinsAlexander Thompson. (2021) Role of the HOXA cluster in HSC emergence and blood cancer. Biochemical Society Transactions 49:4, pages 1817-1827.
Crossref
Fabian Lang, Lydia Wunderle, Susanne Badura, Eberhard Schleyer, Monika Brüggemann, Hubert Serve, Susanne Schnittger, Nicola Gökbuget, Heike Pfeifer, Sebastian Wagner, Kevin Ashelford, Gesine Bug & Oliver G. Ottmann. (2020) A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia. BMC Pharmacology and Toxicology 21:1.
Crossref
Chao Guo, Ya-yue Gao, Qian-qian Ju, Chun-xia Zhang, Ming Gong & Zhen-ling Li. (2020) LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia. BMC Cancer 20:1.
Crossref
Chao Guo, Qian-qian Ju, Chun-xia Zhang, Ming Gong, Zhen-ling Li & Ya-yue Gao. (2020) Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia. BMC Cancer 20:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.